The ‘All of Us’ Research Program: Innovation and Precision Medicine

Joseph Priestley Society
Thursday, February 10, 2022
1:00 p.m.–2:00 p.m. EST (UTC -5)

Our February Joseph Priestley Society program features Sheri Schully, acting chief medical and scientific officer of this NIH-led program.

The mission of the All of Us research program is to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us. The program aims to partner with one million or more people across the United States to build one of the most diverse biomedical data resources of its kind, to help researchers gain better insights into the biological, environmental, social, and behavioral factors that influence health. All of Us is led by the National Institutes of Health and collaborates with more than 100 universities, medical centers, technology companies, and community organizations across the country. The program launched the beta version of its data analysis platform, the Researcher Workbench, in 2020. The platform is a component of the larger Research Hub, built with the aim of creating a national, open resource for all. This talk will go in-depth about the history, goals, and potential for impact of the program.
 

About the Speaker

sheri-schully.jpg

Sheri Schully headshot

Sheri Schully

Sheri Schully is the acting chief medical and scientific officer of the All of Us (AOU) research program. Prior to this role, she was a team lead and senior advisor for disease prevention in the Office of Disease Prevention (ODP). There she led the effort to systematically monitor NIH investments in prevention research and assess the progress of that research. She also served as the team lead for the knowledge integration team as well as a program officer in the epidemiology and genomics research program at the National Cancer Institute (NCI), which first she joined as a presidential management fellow in 2005. Schully has authored or coauthored more than 70 papers, many focusing on the translation of genomic technologies into clinical and public health practice. She earned both a PhD in biological sciences with a concentration in population genetics and a BS in zoology with a minor in chemistry from Louisiana State University.

 

About the Series

The Joseph Priestley Society (JPS) promotes a deeper understanding of science, technology, and industry, with an emphasis on innovation and entrepreneurship. Speakers are leaders from a wide variety of large and small chemical companies and the financial, consulting, and academic communities.
 

For more information about this event, please contact jps@sciencehistory.org.